Dudley Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.8M Buy
44,577
+2
+0% +$528 4.57% 4
2026
Q2
$11.3M Buy
44,575
+17
+0% +$3.96K 4.52% 5
2026
Q1
$10.9M Sell
44,558
-925
-2% -$215K 4.8% 4
2025
Q4
$9.41M Buy
45,483
+248
+0.5% +$49K 4.09% 5
2025
Q3
$8.39M Sell
45,235
-107
-0.2% -$18.3K 3.77% 4
2025
Q2
$6.93M Buy
45,342
+68
+0.2% +$10.5K 3.46% 5
2025
Q1
$7.51M Sell
45,274
-1,266
-3% -$198K 3.93% 4
2024
Q4
$6.73M Sell
46,540
-87
-0.2% -$13.5K 3.39% 4
2024
Q3
$7.56M Sell
46,627
-47
-0.1% -$7.49K 3.91% 4
2024
Q2
$6.82M Sell
46,674
-96
-0.2% -$14.3K 3.78% 4
2024
Q1
$7.38M Buy
46,770
+473
+1% +$75.3K 4.31% 4
2023
Q4
$7.26M Buy
46,297
+103
+0.2% +$15.8K 4.63% 3
2023
Q3
$7.19M Sell
46,194
-212
-0.5% -$35K 5.05% 3
2023
Q2
$7.68M Buy
46,406
+235
+0.5% +$37.9K 5.16% 3
2023
Q1
$7.16M Buy
46,171
+318
+0.7% +$51.3K 4.86% 3
2022
Q4
$8.1M Buy
+45,853
New +$7.92M 5.67% 2

Other funds holding JNJ

Dudley Capital Management's JNJ Position: Q3 2026 in Review

Dudley Capital Management increased its Johnson & Johnson (JNJ) stake by 0% in Q3 2026, buying an estimated $528 and bringing the position to 44,577 shares worth $11.8M. The position accounts for 4.57% of the portfolio, ranked #4.

Dudley Capital Management first reported a position in JNJ in Q4 2022 and has held it in 16 quarters since. 4,739 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Dudley Capital Management held 44,577 shares of Johnson & Johnson worth $11.8M as of Q3 2026.
  • Dudley Capital Management bought 2 Johnson & Johnson shares in Q3 2026, an estimated $528.
  • Johnson & Johnson made up 4.57% of Dudley Capital Management's portfolio in Q3 2026, its #4 holding.
  • Dudley Capital Management first reported a position in Johnson & Johnson in Q4 2022 and has held it in 16 quarters since.
  • 4,739 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Dudley Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.